Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | polymerase (DNA directed), beta | Starlite/ChEMBL | No references |
Homo sapiens | estrogen receptor 2 (ER beta) | Starlite/ChEMBL | No references |
Mus musculus | RAR-related orphan receptor gamma | Starlite/ChEMBL | No references |
Homo sapiens | glucagon-like peptide 1 receptor | Starlite/ChEMBL | No references |
Homo sapiens | polymerase (DNA directed) iota | Starlite/ChEMBL | No references |
Homo sapiens | nuclear factor, erythroid 2-like 2 | Starlite/ChEMBL | No references |
Homo sapiens | tumor protein p53 | Starlite/ChEMBL | No references |
Influenza A virus | Nonstructural protein 1 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | estrogen receptor 2 (ER beta) | 495 aa | 418 aa | 25.8 % |
Loa Loa (eye worm) | pigment dispersing factor receptor c | glucagon-like peptide 1 receptor | 463 aa | 388 aa | 25.8 % |
Mycobacterium tuberculosis | Hypothetical protein | Nonstructural protein 1 | 230 aa | 202 aa | 23.8 % |
Trypanosoma cruzi | mitochondrial DNA polymerase beta-PAK, putative | polymerase (DNA directed), beta | 335 aa | 303 aa | 32.3 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | acyl-CoA desaturase | 0.0242 | 0.5342 | 1 |
Leishmania major | fatty-acid desaturase, putative | 0.0306 | 0.7134 | 0.8041 |
Trypanosoma cruzi | fatty acid desaturase, putative | 0.0242 | 0.5342 | 0.6081 |
Trypanosoma cruzi | fatty acid desaturase, putative | 0.0242 | 0.5342 | 0.6081 |
Brugia malayi | Fatty acid desaturase family protein | 0.0064 | 0.0354 | 0.0204 |
Loa Loa (eye worm) | hypothetical protein | 0.0064 | 0.0354 | 0.023 |
Leishmania major | stearic acid desaturase, putative | 0.0306 | 0.7134 | 0.8041 |
Trypanosoma brucei | mitochondrial DNA polymerase beta | 0.0365 | 0.8785 | 1 |
Trypanosoma brucei | fatty acid desaturase, putative | 0.0306 | 0.7134 | 0.812 |
Trypanosoma cruzi | mitochondrial DNA polymerase beta, putative | 0.0365 | 0.8785 | 1 |
Brugia malayi | Delta5 fatty acid desaturase | 0.0064 | 0.0354 | 0.0204 |
Echinococcus multilocularis | tumor protein p63 | 0.0408 | 1 | 1 |
Trypanosoma cruzi | delta-4 fatty acid desaturase, putative | 0.0064 | 0.0354 | 0.0403 |
Trypanosoma cruzi | mitochondrial DNA polymerase beta, putative | 0.0365 | 0.8785 | 1 |
Trypanosoma cruzi | sphingolipid delta 4 desaturase, putative | 0.0064 | 0.0354 | 0.0403 |
Trypanosoma cruzi | fatty acid desaturase, putative | 0.0064 | 0.0354 | 0.0403 |
Trypanosoma brucei | delta-4 fatty acid desaturase | 0.0064 | 0.0354 | 0.0403 |
Trypanosoma cruzi | mitochondrial DNA polymerase beta-PAK, putative | 0.0173 | 0.3401 | 0.3871 |
Onchocerca volvulus | 0.0064 | 0.0354 | 0.017 | |
Brugia malayi | Fatty acid desaturase family protein | 0.0064 | 0.0354 | 0.0204 |
Leishmania major | mitochondrial DNA polymerase beta-PAK, putative | 0.0173 | 0.3401 | 0.3614 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.006 | 0.025 | 0.0026 |
Trypanosoma cruzi | delta-4 fatty acid desaturase, putative | 0.0064 | 0.0354 | 0.0403 |
Leishmania major | mitochondrial DNA polymerase beta | 0.0365 | 0.8785 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.025 | 0.0026 |
Onchocerca volvulus | 0.0306 | 0.7134 | 1 | |
Schistosoma mansoni | fatty acid desaturase | 0.0064 | 0.0354 | 1 |
Mycobacterium ulcerans | hypothetical protein | 0.0192 | 0.3947 | 1 |
Trypanosoma cruzi | fatty acid desaturase, putative | 0.0064 | 0.0354 | 0.0403 |
Trypanosoma cruzi | fatty acid desaturase, putative | 0.0306 | 0.7134 | 0.812 |
Loa Loa (eye worm) | fatty acid desaturase | 0.0064 | 0.0354 | 0.023 |
Trypanosoma cruzi | mitochondrial DNA polymerase beta-PAK, putative | 0.0062 | 0.0314 | 0.0358 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0192 | 0.3947 | 1 |
Trypanosoma brucei | mitochondrial DNA polymerase beta-PAK | 0.0173 | 0.3401 | 0.3871 |
Trypanosoma brucei | cytochrome b5-dependent oleate desaturase | 0.0064 | 0.0354 | 0.0403 |
Toxoplasma gondii | sphingolipid delta 4 desaturase/c-4 hydroxylase protein des2 family protein | 0.0064 | 0.0354 | 1 |
Trypanosoma brucei | delta-6 fatty acid desaturase, putative | 0.0064 | 0.0354 | 0.0403 |
Plasmodium falciparum | stearoyl-CoA desaturase | 0.0242 | 0.5342 | 0.5 |
Trypanosoma cruzi | cytochrome b5-dependent oleate desaturase | 0.0064 | 0.0354 | 0.0403 |
Trypanosoma brucei | sphingolipid delta 4 desaturase, putative | 0.0064 | 0.0354 | 0.0403 |
Brugia malayi | acyl-CoA desaturase | 0.0242 | 0.5342 | 1 |
Loa Loa (eye worm) | FAT-3 protein | 0.0064 | 0.0354 | 0.023 |
Onchocerca volvulus | 0.0306 | 0.7134 | 1 | |
Plasmodium vivax | stearoyl-CoA desaturase (acyl-CoA desaturase, faty acid desaturase), putative | 0.0242 | 0.5342 | 0.5 |
Loa Loa (eye worm) | fatty acid desaturase | 0.0064 | 0.0354 | 0.023 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 2.998048311 um | PUBCHEM_BIOASSAY: Estrogen Receptor-beta Coactivator Binding Inhibitors ELISA Secondary Assay. (Class of assay: confirmatory) [Related pubchem assays: 633 (Primary screen preceding this ELISA dose response confirmation assay.), 733 (Primary dose response assay preceding this ELISA dose response confirmation assay.)] | ChEMBL. | No reference |
IC50 (binding) | = 19.55596 um | PUBCHEM_BIOASSAY: Estrogen Receptor-beta Coactivator Binding Inhibitors Dose Response Confirmation. (Class of assay: confirmatory) [Related pubchem assays: 633 (Primary screen preceding this dose response confirmation assay.)] | ChEMBL. | No reference |
Potency (functional) | = 0.3162 um | PUBCHEM_BIOASSAY: VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 5.1735 uM | PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648] | ChEMBL. | No reference |
Potency (functional) | 10.4179 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | = 11.2202 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Influenza NS1 Protein Function. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 12.5893 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of DNA Polymerase Beta. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 15.8489 uM | PUBCHEM_BIOASSAY: qHTS assay for re-activators of p53 using a Luc reporter. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504709] | ChEMBL. | No reference |
Potency (functional) | 15.8489 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Potency (functional) | 19.9526 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 50.1187 um | PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins. (Class of assay: confirmatory) [Related pubchem assays: 1011 (Confirmation Concentration-Response Assay for Inhibitors of the Schistosoma mansoni Redox Cascade ), 448 (Schistosoma Mansoni Peroxiredoxins (Prx2) and thioredoxin glutathione reductase (TGR) coupled assay)] | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.